Oriola Oyj (HEL:ORIOLA)

Market Cap	183.22M
Revenue (ttm)	1.68B
Net Income (ttm)	-20.10M
Shares Out	181.41M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	17.35
Dividend	0.07 (6.93%)
Ex-Dividend Date	Apr 3, 2025

Volume	162,622
Average Volume	154,980
Open	1.008
Previous Close	1.006
Day's Range	0.999 - 1.038
52-Week Range	0.850 - 1.156
Beta	0.54
RSI	43.45
Earnings Date	Apr 29, 2025

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1907
• Employees: 934
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: ORIOLA

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.